EXPD vs PALI · P/E 26, rev $10.60B vs P/E 15, $316.3M cap
Expeditors International of Washington, Inc. (EXPD) versus Palisade Bio Inc (PALI) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Palisade Bio Inc (PALI) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported PALI revenue for 2024-12-31 was $0. Net income was -$14.4M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
Not investment advice. Open the EXPD and PALI stock pages for the full models.
Not investment advice.